0
Article |

Arachidonic Acid: A Common Link in the Biology of Schizophrenia?

M. Peet, MB, FRCPsych; J. D. E. Laugharne, MB, MRCPsych; D. F. Horrobin, DPhil; G. P. Reynolds, PhD
Arch Gen Psychiatry. 1994;51(8):665-666. doi:10.1001/archpsyc.1994.03950080077012
Text Size: A A A
Published online

There is evidence of abnormalities of prostaglandin synthesis and action in schizophrenia; thus, there are reports of increased activity of phospholipase A2,1 increased plasma levels of prostaglandin E2,2 and subsensitivity of platelet prostaglandin receptors.3 The main precursor for prostaglandin synthesis is arachidonic acid, which is released from membrane phospholipid by phospholipase A2. One possible consequence of increased phospholipase A2 activity would be the depletion of arachidonic acid.

In the course of a study of membrane fatty acids, we measured4 red blood cell membrane arachidonic acid in a group of 23 hospitalized neuroleptic-treated schizophrenic patients (16 men and 7 women) aged 28 to 75 years (mean age, 55 years) and 16 control subjects matched for age and sex. We also measured the plasma levels of thiobarbituric acid reactive substances (TBARS) in the same blood samples. Thiobarbituric acid reactive substances are a measure of

REFERENCES

Gattaz WF, Hubner CK, Nevalainan TJ, Thuren T, Kinnunen PKJ.  Increased serum phospholipase A2 activity in schizophrenia: a replication study . Biol Psychiatry . 1990;;28:495-501.
Kaiya H, Vematsu M, Ofuji M, Nishida A, Takeuchi K, Nozaki M, Indaka E.  Elevated plasma prostaglandin E2 levels in schizophrenia . J Neural Transm Gen Sect . 1989;;77:39-46.
Kanof PD, Davidson M, Johns CA, Mohs RC, Davis KL.  Clinical correlates of platelet prostaglandin receptor subsensitivity in schizophrenia . Am J Psychiatry . 1987;;144:1556-1560.
Manku MS, Horrobin DF, Huang Y-S, Morse N.  Fatty acids in plasma and red cell membranes . Lipids . 1983;;18:906-908.
Halliwell B, Gutteridge JMC.  The thiobarbituric (TBA) test . In: Free Radicals in Biology and Medicine . Oxford, England: Clarendon Press; 1989;:228-233.
Pettegrew JW, Keshaven MS, Panchalingam K, Strychor S, Kaplan DB, Tretta M, Allen M.  Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first episode drug-naive schizophrenics . Arch Gen Psychiatry . 1991;;48:563-568.
Barbour B, Szatkowski M, Ingledew N, Attwell D.  Arachidonic acid induces a prolonged inhibition of glutamate uptake into glial cells . Nature . 1989;;342:918-920.
Carlsson M, Carlsson A.  Schizophrenia: a subcortical neurotransmitter imbalance syndrome? Schizophr Bull . 1990;;16:425-432.
Carlsson SE, Werkman SH, Peeples JM, Cooke RJ, Wilson WM.  Plasma phospholipid arachidonic acid and growth and development of pre-term infants . In: Koletzko B, Okken A, Rey J, Salle B, Van Biervielt JP, eds. Recent Advances in Infant Feeding . Stuttgart, Germany: Georg Thieme Verlag; 1992;.
Royston MC, Lewis SW.  Brain pathology in schizophrenia: developmental or degenerative? Curr Opin Psychiatry . 1993;;6:70-73.
Pellmar TC, Neel KL, Lee KH.  Free radicals mediate peroxidative damage in guinea pig hippocampus in vitro . J Neurosci Res . 1989;;24:437-444.
Buckman TD, Kling AS, Eiduson S, Sutphin MS, Steinberg A.  Glutathione peroxidase and CT-scan abnormalities in schizophrenia . Biol Psychiatry . 1987;;22:1349-1356.
Christinsen O, Christinsen E.  Fat consumption and schizophrenia . Acta Psychiatr Scand . 1988;;78:587-591.

First Page Preview

First page PDF preview

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

Gattaz WF, Hubner CK, Nevalainan TJ, Thuren T, Kinnunen PKJ.  Increased serum phospholipase A2 activity in schizophrenia: a replication study . Biol Psychiatry . 1990;;28:495-501.
Kaiya H, Vematsu M, Ofuji M, Nishida A, Takeuchi K, Nozaki M, Indaka E.  Elevated plasma prostaglandin E2 levels in schizophrenia . J Neural Transm Gen Sect . 1989;;77:39-46.
Kanof PD, Davidson M, Johns CA, Mohs RC, Davis KL.  Clinical correlates of platelet prostaglandin receptor subsensitivity in schizophrenia . Am J Psychiatry . 1987;;144:1556-1560.
Manku MS, Horrobin DF, Huang Y-S, Morse N.  Fatty acids in plasma and red cell membranes . Lipids . 1983;;18:906-908.
Halliwell B, Gutteridge JMC.  The thiobarbituric (TBA) test . In: Free Radicals in Biology and Medicine . Oxford, England: Clarendon Press; 1989;:228-233.
Pettegrew JW, Keshaven MS, Panchalingam K, Strychor S, Kaplan DB, Tretta M, Allen M.  Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first episode drug-naive schizophrenics . Arch Gen Psychiatry . 1991;;48:563-568.
Barbour B, Szatkowski M, Ingledew N, Attwell D.  Arachidonic acid induces a prolonged inhibition of glutamate uptake into glial cells . Nature . 1989;;342:918-920.
Carlsson M, Carlsson A.  Schizophrenia: a subcortical neurotransmitter imbalance syndrome? Schizophr Bull . 1990;;16:425-432.
Carlsson SE, Werkman SH, Peeples JM, Cooke RJ, Wilson WM.  Plasma phospholipid arachidonic acid and growth and development of pre-term infants . In: Koletzko B, Okken A, Rey J, Salle B, Van Biervielt JP, eds. Recent Advances in Infant Feeding . Stuttgart, Germany: Georg Thieme Verlag; 1992;.
Royston MC, Lewis SW.  Brain pathology in schizophrenia: developmental or degenerative? Curr Opin Psychiatry . 1993;;6:70-73.
Pellmar TC, Neel KL, Lee KH.  Free radicals mediate peroxidative damage in guinea pig hippocampus in vitro . J Neurosci Res . 1989;;24:437-444.
Buckman TD, Kling AS, Eiduson S, Sutphin MS, Steinberg A.  Glutathione peroxidase and CT-scan abnormalities in schizophrenia . Biol Psychiatry . 1987;;22:1349-1356.
Christinsen O, Christinsen E.  Fat consumption and schizophrenia . Acta Psychiatr Scand . 1988;;78:587-591.

Correspondence

CME Course for:


You need to register in order to view this quiz.


To understand the clinical management of acute heart failure syndromes.
Accreditation Information The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
To view and print your certificate and access a summary of your CME courses go to My CME.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.